2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group
Open Access
- 12 June 2009
- journal article
- guideline
- Published by Elsevier in Annals of Oncology
- Vol. 20 (9) , 1459-1471
Abstract
Background: In view of the lack of recommendations on central venous catheter (CVC)-associated thrombosis in cancer patients, we established guidelines according to the well-standardized Standards, Options and Recommendations methodology. Material and methods: A literature review (1990–2007) on CVC-associated thrombosis was carried out. The guidelines were developed on the basis of the corresponding levels of evidence derived from analysis of the 36 of 175 publications selected. They were then peer reviewed by 65 independent experts. Results: For the prevention of CVC-associated thrombosis, the distal tip of the CVC should be placed at the junction between the superior cava vein and right atrium; anticoagulants are not recommended. Treatment of CVC-associated thrombosis should be based on the prolonged use of low-molecular weight heparins. Maintenance of the catheter is justified if it is mandatory, functional, in the right position, and not infected, with a favorable clinical evolution under close monitoring; anticoagulant treatment should then be continued as long as the catheter is present. Conclusions: Several rigorous studies do not support the use of anticoagulants for the prevention of CVC-associated thrombosis. Treatment of CVC-associated thrombosis relies on the same principles as those applied in the treatment of established thrombosis in cancer patients.Keywords
Funding Information
- French Federation of Cancer Centers and the French National Cancer League
This publication has 45 references indexed in Scilit:
- Thromboprophylaxis in cancer patients with central venous cathetersThrombosis and Haemostasis, 2008
- Thrombotic and infectious complications of central venous catheters in patients with hematological malignanciesAnnals of Oncology, 2007
- The Use of Low-Dose Warfarin as Prophylaxis for Central Venous Catheter Thrombosis in Patients With Cancer: A Meta-AnalysisOncology Nursing Forum, 2007
- High incidence of INR alteration in gastrointestinal cancer patients treated with mini-dose warfarin and 5-fluorouracil-based regimensAnnals of Oncology, 2005
- Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion portsSupportive Care in Cancer, 2004
- Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological diseaseThrombosis and Haemostasis, 2004
- Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE projectQuality and Safety in Health Care, 2003
- A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancyEuropean Journal of Cancer, 1997
- Hickman catheters: left‐sided insertion, male gender, and obesity are associated with an increased risk of complicationsAustralian and New Zealand Journal of Medicine, 1996
- Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator.Thorax, 1993